Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata

Kinnaird, J. H., Singh, M., Gillan, V. , Weir, W. , Calder, E. D.D., Hostettler, I., Tatu, U., Devaney, E. and Shiels, B. R. (2017) Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata. Cellular Microbiology, 19(3), e12669. (doi:10.1111/cmi.12669) (PMID:27649068) (PMCID:PMC5333456)

Kinnaird, J. H., Singh, M., Gillan, V. , Weir, W. , Calder, E. D.D., Hostettler, I., Tatu, U., Devaney, E. and Shiels, B. R. (2017) Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata. Cellular Microbiology, 19(3), e12669. (doi:10.1111/cmi.12669) (PMID:27649068) (PMCID:PMC5333456)

[img]
Preview
Text
128840.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

HSP90 chaperones are essential regulators of cellular function, as they ensure the appropriate conformation of multiple key client proteins. Four HSP90 isoforms were identified in the protozoan parasite Theileria annulata. Partial characterisation was undertaken for three and localisation confirmed for cytoplasmic (TA12105); endoplasmic reticulum (TA06470) and apicoplast (TA10720) forms. ATPase activity and binding to the HSP90 inhibitor geldanamycin, were demonstrated for recombinant TA12105 and all three native forms could be isolated to varying extents by binding to geldanamycin beads. Because it is essential, HSP90 is considered a potential therapeutic drug target. Resistance to the only specific Theileriacidal drug is increasing and one challenge for design of drugs that target the parasite is to limit the effect on the host. An in vitro cell culture system that allows comparison between uninfected bovine cells and the T. annulata-infected counterpart was utilised to test the effects of geldanamycin and the derivative 17-AAG. T. annulata-infected cells had greater tolerance to geldanamycin than uninfected cells yet exhibited significantly more sensitivity to 17-AAG. These findings suggest that parasite HSP90 isoform (s) can alter the drug sensitivity of infected host cells and that members of the Theileria HSP90 family are potential targets worthy of further investigation.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Devaney, Professor Eileen and Weir, Dr William and Shiels, Professor Brian and Calder, Mr Ewen and Gillan, Dr Victoria and Kinnaird, Dr Jane
Authors: Kinnaird, J. H., Singh, M., Gillan, V., Weir, W., Calder, E. D.D., Hostettler, I., Tatu, U., Devaney, E., and Shiels, B. R.
College/School:College of Medical Veterinary and Life Sciences > Institute of Biodiversity Animal Health and Comparative Medicine
Journal Name:Cellular Microbiology
Publisher:Wiley
ISSN:1462-5814
ISSN (Online):1462-5822
Published Online:20 October 2016
Copyright Holders:Copyright © 2016 The Authors
First Published:First published in Cellular Microbiology 19(3):e12669
Publisher Policy:Reproduced under a creative commons license

University Staff: Request a correction | Enlighten Editors: Update this record

Project CodeAward NoProject NamePrincipal InvestigatorFunder's NameFunder RefLead Dept
632991Hsp90 as a modulator of pathogenicity, virulence and transmission in Theileria and BabesiaEileen DevaneyBiotechnology and Biological Sciences Research Council (BBSRC)BB/L004542/1RI BIODIVERSITY ANIMAL HEALTH & COMPMED